Groundbreaking New FDA-Approved Drug for Acute Leukemia First Administered at Florida Cancer Specialists & Research Institute Sarasota Drug Development Unit [Yahoo! Finance]
HCA Healthcare, Inc. (HCA)
Last hca healthcare, inc. earnings: 4/21 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.hcahealthcare.com
Company Research
Source: Yahoo! Finance
Food and Drug Administration (FDA) approved revumenib , a revolutionary drug for relapsed or refractory acute leukemia with a KMT2A translocation on November 15, 2024 . This life-saving therapy, first administered to a Florida Cancer Specialists & Research Institute, LLC (FCS) patient at its Sarasota Drug Development Unit (DDU) in 2019 as part of a Phase 1 clinical trial, is now available to patients nationwide. The very first patient to ever receive this groundbreaking treatment was referred by FCS medical oncologist/hematologist Muhammad Imam , MD to FCS Director of Drug Development Manish R. Patel , MD at the FCS Sarasota DDU, one of three early-phase clinical trial sites within the statewide practice. This milestone underscores FCS' fundamental role in the development of this drug, which has now gained FDA approval for its remarkable ability to target and treat MLL-rearranged leukemia. "This latest FDA approval of revumenib is a testament to the power of innovation and collabo
Show less
Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCA alerts
High impacting HCA Healthcare, Inc. news events
Weekly update
A roundup of the hottest topics
HCA
News
- HCA Healthcare, Inc. (NYSE: HCA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.MarketBeat
- Franklin Equity Income SMA Q3 2024 Commentary [Seeking Alpha]Seeking Alpha
- AdventHealth West Florida Hospitals Using AI Technology for Early Colon Cancer Detection [Yahoo! Finance]Yahoo! Finance
- Report finds fall in Hospital Price Transparency Rule compliance among US hospitals [Yahoo! Finance]Yahoo! Finance
- Tenet Healthcare Partners With Commure for Ambient AI Platform [Yahoo! Finance]Yahoo! Finance
HCA
Earnings
- 10/25/24 - Miss
HCA
Sec Filings
- 11/18/24 - Form 4
- 11/18/24 - Form 4
- 11/14/24 - Form 4
- HCA's page on the SEC website